Cephalon
North America, Pennsylvania, United States, Malvern
Description
Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the
Investor Profile
Cephalon has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 17% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series E, Corporate Round rounds (top funding stages).
- Majority of deals are located in Japan, United States.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series Unknown (67%)
- Series E (17%)
- Corporate Round (17%)
Country Focus
- Japan (83%)
- United States (17%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
